Literature DB >> 27221387

Effects of ozone (O3) therapy on cisplatin-induced ototoxicity in rats.

Hasan Emre Koçak1, Ümit Taşkın2, Salih Aydın2, Mehmet Faruk Oktay2, Serdar Altınay3, Duygu Sultan Çelik4, Kadir Yücebaş5, Bengül Altaş2.   

Abstract

The aim of this study is to investigate the effect of rectal ozone and intratympanic ozone therapy on cisplatin-induced ototoxicity in rats. Eighteen female Wistar albino rats were included in our study. External auditory canal and tympanic membrane examinations were normal in all rats. The rats were randomly divided into three groups. Initially, all the rats were tested with distortion product otoacoustic emissions (DPOAE), and emissions were measured normally. All rats were injected with 5-mg/kg/day cisplatin for 3 days intraperitoneally. Ototoxicy had developed in all rats, as confirmed with DPOAE after 1 week. Rectal and intratympanic ozone therapy group was Group 1. No treatment was administered for the rats in Group 2 as the control group. The rats in Group 3 were treated with rectal ozone. All the rats were tested with DPOAE under general anesthesia, and all were sacrificed for pathological examination 1 week after ozone administration. Their cochleas were removed. The outer hair cell damage and stria vascularis damage were examined. In the statistical analysis conducted, a statistically significant difference between Group 1 and Group 2 was observed in all frequencies according to the DPOAE test. In addition, between Group 2 and Group 3, a statistically significant difference was observed in the DPOAE test. However, a statistically significant difference was not observed between Group 1 and Group 3 according to the DPOAE test. According to histopathological scoring, the outer hair cell damage score was statistically significantly high in Group 2 compared with Group 1. In addition, the outer hair cell damage score was also statistically significantly high in Group 2 compared with Group 3. Outer hair cell damage scores were low in Group 1 and Group 3, but there was no statistically significant difference between these groups. There was no statistically significant difference between the groups in terms of stria vascularis damage score examinations. Systemic ozone gas therapy is effective in the treatment of cell damage in cisplatin-induced ototoxicity. The intratympanic administration of ozone gas does not have any additional advantage over the rectal administration.

Entities:  

Keywords:  Cisplatin; Otoacoustic emission; Ototoxicy; Ozone

Mesh:

Substances:

Year:  2016        PMID: 27221387     DOI: 10.1007/s00405-016-4104-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

Review 1.  Is it true that ozone is always toxic? The end of a dogma.

Authors:  Velio Bocci
Journal:  Toxicol Appl Pharmacol       Date:  2006-06-27       Impact factor: 4.219

Review 2.  Ozone therapy in medicine and dentistry.

Authors:  Carlos Goes Nogales; Patrícia Helena Ferrari; Efraim Olszewer Kantorovich; José Luiz Lage-Marques
Journal:  J Contemp Dent Pract       Date:  2008-05-01

3.  Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract.

Authors:  Zahide Mine Yazici; Aysenur Meric; Ahmet Midi; Yasar Volkan Arınc; Volkan Kahya; Gunter Hafız
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-27       Impact factor: 2.503

4.  Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs.

Authors:  Masa-aki Teranishi; Tsutomu Nakashima
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-02       Impact factor: 1.675

5.  Cisplatin ototoxicity: the importance of baseline audiometry.

Authors:  J L Nagy; D J Adelstein; C W Newman; L A Rybicki; T W Rice; P Lavertu
Journal:  Am J Clin Oncol       Date:  1999-06       Impact factor: 2.339

6.  L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.

Authors:  J G Feghali; W Liu; T R Van De Water
Journal:  Laryngoscope       Date:  2001-07       Impact factor: 3.325

7.  Light microscopy study of cisplatin-induced ototoxicity in rats.

Authors:  M R de Freitas; G A de Castro Brito; J V de Carvalho; R M Gomes; M J Barreto Martins; R de Albuquerque Ribeiro
Journal:  J Laryngol Otol       Date:  2009-01-15       Impact factor: 1.469

Review 8.  Cisplatin ototoxicity and protection: clinical and experimental studies.

Authors:  Leonard P Rybak; Debashree Mukherjea; Sarvesh Jajoo; Vickram Ramkumar
Journal:  Tohoku J Exp Med       Date:  2009-11       Impact factor: 1.848

9.  Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.

Authors:  D Thomas Dickey; Leslie L Muldoon; Dale F Kraemer; Edward A Neuwelt
Journal:  Hear Res       Date:  2004-07       Impact factor: 3.208

10.  Aminoguanidine reduces cisplatin ototoxicity.

Authors:  Thomas C Kelly; Craig A Whitworth; Kazim Husain; Leonard P Rybak
Journal:  Hear Res       Date:  2003-12       Impact factor: 3.208

View more
  3 in total

Review 1.  Use of Gases to Treat Cochlear Conditions.

Authors:  Jay C Buckey
Journal:  Front Cell Neurosci       Date:  2019-04-24       Impact factor: 5.505

Review 2.  Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects.

Authors:  Bernardino Clavo; Francisco Rodríguez-Esparragón; Delvys Rodríguez-Abreu; Gregorio Martínez-Sánchez; Pedro Llontop; David Aguiar-Bujanda; Leandro Fernández-Pérez; Norberto Santana-Rodríguez
Journal:  Antioxidants (Basel)       Date:  2019-11-26

Review 3.  Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.

Authors:  Bernardino Clavo; Gregorio Martínez-Sánchez; Francisco Rodríguez-Esparragón; Delvys Rodríguez-Abreu; Saray Galván; David Aguiar-Bujanda; Juan A Díaz-Garrido; Silvia Cañas; Laura B Torres-Mata; Himar Fabelo; Teresa Téllez; Norberto Santana-Rodríguez; Leandro Fernández-Pérez; Gustavo Marrero-Callico
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.